Chemomab Therapeutics Ltd.
Balance Sheet
| Line Item | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $20.8M | $13.5M | $10.7M | $9.9M | $13.8M | $15.2M | $37.7M | $45.4M |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $33.8M | $41.7M | $48.7M | $54.8M | $59.3M | $62.7M | $65.8M | $68.8M |
| Property, Plant & Equipment | $352.0K | $367.0K | $380.0K | $355.0K | $358.0K | $357.0K | $234.0K | $243.0K |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $35.0M | $43.1M | $50.2M | $56.4M | $61.0M | $64.4M | $67.4M | $70.5M |
| Liabilities | ||||||||
| Accounts Payable | $2.2M | $1.7M | $1.2M | $1.4M | $1.5M | $1.3M | $481.0K | $472.0K |
| Total Current Liabilities | $7.0M | $6.7M | $5.5M | $4.4M | $3.5M | $2.7M | $1.6M | $2.2M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $7.1M | $6.8M | $5.6M | $4.5M | $3.7M | $2.9M | $1.9M | $2.5M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-72.6M | $-63.8M | $-55.5M | $-47.5M | $-41.3M | $-36.2M | $-31.1M | $-28.2M |
| Total Stockholders' Equity | $28.0M | $36.2M | $44.6M | $51.8M | $57.2M | $61.5M | $65.5M | $68.0M |